Morgan Stanley Moderna, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Moderna, Inc. stock. As of the latest transaction made, Morgan Stanley holds 3,509,089 shares of MRNA stock, worth $130 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,509,089

Previous 5,006,520 29.91%

Holding current value

$130 Million

Previous $595 Million 60.55%

% of portfolio

0.02%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $95.3 Million - $187 Million	-1,497,431 Reduced 29.91%	3,509,089 $235 Million
Q2 2024 Oct 17, 2024	SELL	$101.21 - $166.61 $49.3 Million - $81.2 Million	-487,445 Reduced 8.87%	5,006,520 $595 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $49.3 Million - $81.2 Million	-487,445 Reduced 8.87%	5,006,520 $595 Million
Q1 2024 Oct 17, 2024	BUY	$85.37 - $115.44 $41.6 Million - $56.3 Million	487,445 Added 9.74%	5,493,965 $585 Million
Q1 2024 Aug 16, 2024	BUY	$85.37 - $115.44 $94.3 Million - $128 Million	1,104,857 Added 25.17%	5,493,965 $585 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $94.3 Million - $128 Million	1,104,857 Added 25.17%	5,493,965 $585 Million
Q4 2023 Aug 16, 2024	SELL	$69.51 - $104.43 $42.9 Million - $64.5 Million	-617,412 Reduced 12.33%	4,389,108 $436 Million
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $64.2 Million - $96.4 Million	-922,906 Reduced 17.37%	4,389,108 $436 Million
Q3 2023 Nov 15, 2023	SELL	$96.41 - $126.61 $48.7 Million - $63.9 Million	-505,071 Reduced 8.68%	5,312,014 $549 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $103 Million - $139 Million	866,512 Added 17.5%	5,817,085 $707 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $104 Million - $150 Million	763,220 Added 18.23%	4,950,573 $760 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $79.3 Million - $141 Million	670,284 Added 19.06%	4,187,353 $752 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $4.2 Million - $6.9 Million	35,547 Added 1.02%	3,517,069 $416 Million
Q2 2022 Oct 27, 2022	BUY	$117.13 - $176.59 $66.8 Million - $101 Million	570,718 Added 19.61%	3,481,522 $497 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $66.8 Million - $101 Million	570,718 Added 19.61%	3,481,522 $497 Million
Q1 2022 Oct 27, 2022	SELL	$126.46 - $235.05 $72.2 Million - $134 Million	-570,718 Reduced 16.39%	2,910,804 $501 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $244 Million - $454 Million	-1,930,052 Reduced 39.87%	2,910,804 $501 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $185 Million - $302 Million	-820,531 Reduced 14.49%	4,840,856 $1.23 Billion
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $1.26 Billion - $2.74 Billion	5,661,387 New	5,661,387 $2.18 Billion

Others Institutions Holding MRNA

# of Institutions

952

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account